本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Janux Therapeutics, Inc.

30.01
+0.71002.42%
盘后30.010.00000.00%16:30 EDT
成交量:73.04万
成交额:2,204.62万
市值:17.74亿
市盈率:-23.38
高:31.02
开:29.69
低:29.69
收:29.30
数据加载中...
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]